Analyst Ratings For Misonix, Inc. (NASDAQ:MSON)
Today, BTIG Research initiated coverage on Misonix, Inc. (NASDAQ:MSON) with a Buy with a price target of $29.00.
There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Misonix, Inc. (NASDAQ:MSON) is Buy with a consensus target price of $27.00 per share, a potential 11.07% upside.
Some recent analyst ratings include
- 6/12/2019-Misonix, Inc. (NASDAQ:MSON) has coverage initiated with a Buy ➝ Buy rating and $29.00 price target
- 9/11/2018-Misonix, Inc. (NASDAQ:MSON) has coverage initiated with a Buy rating and $28.00 price target
- 8/24/2018-Misonix, Inc. (NASDAQ:MSON) has coverage initiated with a Buy rating and $24.00 price target
- On 6/4/2019 Joseph P Dwyer, CFO, bought 500 with an average share price of $23.57 per share and the total transaction amounting to $11,785.00.
- On 2/11/2019 Joseph J Brennan, VP, sold 1,000 with an average share price of $19.45 per share and the total transaction amounting to $19,450.00.
- On 12/6/2018 Joseph J Brennan, VP, sold 8,357 with an average share price of $15.91 per share and the total transaction amounting to $132,959.87.
- On 11/28/2018 Christopher H Wright, VP, sold 10,000 with an average share price of $16.31 per share and the total transaction amounting to $163,100.00.
- On 11/16/2018 Joseph J Brennan, VP, sold 601 with an average share price of $16.27 per share and the total transaction amounting to $9,778.27.
- On 11/15/2018 Joseph P Dwyer, CFO, bought 350 with an average share price of $15.47 per share and the total transaction amounting to $5,414.50.
- On 2/16/2018 Joseph P Dwyer, CFO, bought 300 with an average share price of $9.85 per share and the total transaction amounting to $2,955.00.
About Misonix, Inc. (NASDAQ:MSON)
Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Read More…
Recent Trading Activity for Misonix, Inc. (NASDAQ:MSON)
Shares of Misonix, Inc. closed the previous trading session at 24.31 up +0.35 1.46% with 24.34 shares trading hands.